Evidence map›Paper›PMID 33380863›Full record

ArticleCurrent oncology (Toronto, Ont.)2020

Perspectives of hematology oncology clinicians about integrating palliative care in oncology.

R Booker, S Dunn, M A Earp, A Sinnarajah, P D Biondo, J E Simon

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

R BookerDepartment of Psychosocial Oncology, Tom Baker Cancer Centre, Calgary, AB.
S DunnDepartment of Community Health Sciences, University of Calgary, Calgary, AB.
M A EarpDepartment of Oncology, University of Calgary, Calgary, AB.
A SinnarajahDepartment of Community Health Sciences, University of Calgary, Calgary, AB.
P D BiondoDepartment of Oncology, University of Calgary, Calgary, AB.
J E SimonDepartment of Community Health Sciences, University of Calgary, Calgary, AB.
University of Calgary · CA

Funding

CIHR
6 · The paper itself

Abstract

Patients with hematologic malignancies receive palliative care (pc) less frequently and later than patients with solid tumours. We compared survey responses of hematology oncology clinicians with other oncology clinicians to better understand their challenges with providing primary pc or using secondary pc. Patients' negative perceptions of pc and limited time or competing priorities were challenges for all clinicians. Compared with other oncology clinicians, more hematology oncology clinicians perceived pc referral criteria as too restrictive (40% vs. 22%,

Indexed as

HematologyNeoplasmsHumansMedical OncologyPalliative CareSurveys and Questionnairesclinician perspectivesHematologic malignanciesmixed-methods

Identifiers

PMID33380863
PMCPMC7755435
OpenAlexW3114778996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.